Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.
The study highlights microbial natural products as abundant sources of new drug leads. The researchers’ discovery process involves prioritizing the microbes from the TSRI strain collection and focusing on the ones that are genetically predisposed to produce specific families of natural products. The scientists say this process saves time and resources in comparison to the traditional approaches used to identify these rare molecules.
The study, led by TSRI Professor Ben Shen, was published today in the journal mBio.
Shen and his colleagues uncovered a new family of enediyne natural products, called tiancimycins, (TNMs) which kill selected cancer cells more rapidly and completely in comparison to toxic molecules used in FDA-approved antibody-drug conjugates (ADCs)— monoclonal antibodies attached to cytotoxic drugs that target only cancer cells.
The scientists also discovered several new producers of C-1027, an antitumor antibiotic currently in clinical development, which can produce C-1027 at much higher levels.
It has been more than a decade since Shen first reported on the C-1027 enediyne biosynthetic machinery, and he speculated then that the knowledge obtained from studying biosynthesis of C-1027, and other enediynes, could be used for the discovery of novel enediyne natural products.
“The enediynes represent one of the most fascinating families of natural products for their extraordinary biological activities,” Shen said. “By surveying 3,400 strains from the TSRI collection, we were able to identify 81 strains that harbor genes encoding enediynes. With what we know, we can predict novel structural insights that can be exploited to radically accelerate enediyne-based drug discovery and development.”
“The work described by the Shen group is an excellent example of what can be achieved by coupling state of the art genomic analyses of potential biosynthetic clusters and modern physicochemical techniques,” said David J. Newman, retired chief of the National Cancer Institute’s Natural Products Branch. “As a result of their work, the potential number of enediynes has significantly increased.”
Shen’s method of strain prioritization and genome mining means a far more efficient use of resources involved in the discovery process, targeting only those strains that look to produce the most important natural compounds.
“This study shows that the potential to rapidly discover new enediyne natural products from a large strain collection is within our reach,” said TSRI Research Associate Xiaohui Yan, one of four first authors of the study. “We also show the feasibility of manipulating tiancimycin biosynthesis in vivo, which means that sufficient quantities of these precious natural products can be reliably produced by microbial fermentation for drug development and eventual commercialization.”
Receive an email update when we add a new ANTI-CANCER DRUG article.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Thousands of men with advanced prostate cancer will be denied life-extending wonder drug because NHS watchdog says £30,000-a-year cost per treatment is too highon June 26, 2020 at 4:11 pm
The drug abiraterone cuts the risk of men dying within three years by a third, but tablets are only on the NHS for patients who've had chemotherapy or stopped responding to standard drugs.
- New steroid compounds from deep-water starfish show anticancer activityon June 26, 2020 at 2:06 pm
Russian scientists from Far Eastern Federal University, G. B. Elyakov Pacific Institute of Bioorganic Chemistry, and A.V. Zhirmunsky National Scientific Center for Marine Biology have discovered four ...
- Vitamin D supplements may help prevent serious side effect of anti-cancer therapyon June 26, 2020 at 2:48 am
New research indicates that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy. The findings are published early online in ...
- Study reveals key finding about microbiome of anticancer compound-producing marine invertebrateon June 25, 2020 at 11:59 am
Could the cure for melanoma - the most dangerous type of skin cancer -- be a compound derived from a marine invertebrate that lives at the bottom of the ocean? A group of scientists led by Alison ...
- Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblastomaon June 25, 2020 at 6:03 am
A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival ...
- New Cancer Drug Shows Promise In Preventing Tumors From Growingon June 25, 2020 at 5:40 am
A new cancer drug shows promise in curbing tumor growth It prevents cancer cells from repairing themselves Unlike chemotherapy, the revolutionary drug does not target healthy cells A revolutionary ...
- 'First-in-class' precision cancer drug shows promising results in Phase I trialon June 24, 2020 at 9:07 am
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial. Cancer arises when mutations, or changes to DNA, result in uncontrollable cell growth. The new ...
- Does Medicare cover chemotherapy?on June 24, 2020 at 6:16 am
Medicare provides coverage for chemotherapy. How a person receives the treatment and in what setting will affect which benefit applies. Read on for more.
- Reducing Sugar Uptake Increased Cancer Cells’ Sensitivity to Chemotherapyon June 24, 2020 at 5:00 am
Researchers at Lund University in Sweden have successfully increased cancer cells’ sensitivity to chemotherapy by preventing sugar uptake.
via Bing News